Arthritis By The Numbers - Arthritis Foundation

Nov 27, 2017 - Karen Lomas, PsA facts reviewer; Ms. Lomas, a registered nurse, is an active volunteer and advocate for the Arthritis Foundation. Liz Morasso ...
2MB Sizes 31 Downloads 510 Views
Arthritis By The Numbers

-1-

TABLE OF CONTENTS Introduction.......................................................................................................... 4 Section 1: General Arthritis Facts........................................................................... 7 o Human and Economic Burdens.....................................................................................................8 - Economic Burdens.....................................................................................................................8 - Employment Impact and Medical Cost Burden......................................................................9

Section 2: Osteoarthritis (OA)................................................................................ 12 o Prevalence.......................................................................................................................................14 - US General Population.............................................................................................................14 - U.S. Military Prevalence...........................................................................................................14 - Global Prevalence.....................................................................................................................15 o Human and Economic Burdens.....................................................................................................15 - Health Burdens..........................................................................................................................15 - Economic Burdens.....................................................................................................................17 - Knee, Hip and Shoulder OA Burden.......................................................................................17 - Global Burden...........................................................................................................................19

Section 3: Autoimmune and Inflammatory Arthritis............................................... 21 •Rheumatoid Arthritis (RA)...................................................................................... 23 o Prevalence ......................................................................................................................................23 o Human and Economic Burdens.....................................................................................................23 - Health Burdens..........................................................................................................................23 - Work/Employment Impact.......................................................................................................23 - Medical/Cost Burdens.............................................................................................................24 •Systemic Lupus Erythematosus (SLE or Lupus)......................................................... 25 o Prevalence ......................................................................................................................................25 o Human and Economic Burdens.....................................................................................................26 - Comorbidities and Health Burdens..........................................................................................26 - Pregnancy Impact......................................................................................................................27 - Work/Employment Impact.......................................................................................................27 - Medical/Cost Burdens.............................................................................................................27 •Sjögren’s Syndrome............................................................................................... 30 o Prevalence (Primary Sjögren’s Syndrome).....................................................